| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Feb 9, 2026 | Eikon Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +2,117,760 | 57.82% | ✗ | $38.1M |
| May 25, 2022 | May 27, 2022 | RAPT Therapeutics, Inc. | 10% Owner | Buy | 56.3 | +1,900 | 0.07% | ✗ | $23.7K |
| May 23, 2022 | May 25, 2022 | RAPT Therapeutics, Inc. | 10% Owner | Buy | 75.0 | +26,550 | 0.68% | ✗ | $323.7K |
| May 10, 2022 | May 12, 2022 | RAPT Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,250,000 | 39.72% | ✗ | $13.3M |